The financing was led by T. Rowe Price and Viking Global Investors, a Color spokesperson confirmed to Becker’s Hospital Review, and will allow Color to further scale its efforts to apply genetic testing and genomic findings to preventive healthcare. The funding brings Color’s total financing to more than $200 million, following an $80 million infusion in 2017.
The company spokesperson told Becker’s the average size of its partner contracts has seen appropriately massive gains, increasing more than seven times in value in the past year. In 2019 alone, Color announced partnerships with Apple, Verily, Chicago-based NorthShore University HealthSystem and New Orleans-based Ochsner Health System.
More articles on health IT:
Telehealth, analytics top highest-funded digital health categories in 2019
Vulnerability in Microsoft Windows 10 could allow hackers to spy on targeted computers
Best tech jobs in 2020: Glassdoor
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
